About Maruthi Biosciences
Maruthi Biosciences is a company. Maruthi Biosciences offers products and services including Rencept 360 and Imugraf 1/0.5 mg.
-
Sectors
Healthcare
-
Phone
Locked
- Legal Name Maruthi Biosciences Private Limited
- Jurisdiction Hyderabad, Telangana, India
-
Annual Revenue
$146.5 K (USD)15.73as on Mar 31, 2022
-
Net Profit
$6.48 K (USD)-40.24as on Mar 31, 2022
-
EBITDA
$20.58 K (USD)27.3as on Mar 31, 2022
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Maruthi Biosciences
Maruthi Biosciences offers a comprehensive portfolio of products and services, including Rencept 360 and Imugraf 1/0.5 mg.
Rencept 360 is utilized in organ transplantation processes.
Imugraf 1/0.5 mg is employed in immuno suppression for transplantation-related applications.
Funding Insights of Maruthi Biosciences
Detailed funding history for Maruthi Biosciences
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Maruthi Biosciences
Investment portfolio details for Maruthi Biosciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Maruthi Biosciences
Detailed financials for Maruthi Biosciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Maruthi Biosciences Comparisons
Peer comparison for Maruthi Biosciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Maruthi Biosciences
Detailed competitors of Maruthi Biosciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Maruthi Biosciences
Complete news archive for Maruthi Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Maruthi Biosciences
Annual revenue of Maruthi Biosciences is $146.5K as on Mar 31, 2022.
Maruthi Biosciences Private Limited is noted as having been incorporated in 2009 with a focus on human organ transplantation. It is aimed at pioneering in this field by the next decade, primarily serving the patient community in India, which is recognized as an emerging destination for medical tourism. The company is formed by professionals from the pharma and healthcare sectors, who have contributed decades of experience. Key developments include the announcement of Indias first ABO incompatible kidney transplant using immuno adsorption technology and the initiation of operations in Karnataka via medical symposia, alongside offerings like Rencept 360 and Imugraf.
Maruthi Biosciences offers Rencept 360 and Imugraf 1/0.5 mg.